Primary Immune Deficiency Treatment Consortium (PIDTC): A resource to drive scientific and clinical — Christopher Craig Dvorak (UN
Project Summary/Abstract The Primary Immune Deficiency Treatment Consortium (PIDTC) was founded in 2009 to bring together immunologists, bone marrow transplant (BMT) physicians, and cell/gene therapis
| Project title | Primary Immune Deficiency Treatment Consortium (PIDTC): A resource to drive scientific and clinical |
|---|---|
| Project number | 1R24AI184316-01 |
| PI name | Christopher Craig Dvorak |
| Institution | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO |
| Funding mechanism | R24 |
| Agency | NIAID |
| Award amount | $1.82M |
| Fiscal year | 2024 |
| Project start | 2024-09-03T00:00:00 |
| Project end | 2029-08-31T00:00:00 |
| Abstract | Project Summary/Abstract The Primary Immune Deficiency Treatment Consortium (PIDTC) was founded in 2009 to bring together immunologists, bone marrow transplant (BMT) physicians, and cell/gene therapis |
| Key terms | <0-11 years old><21+ years old><Acceleration><Achievement><Achievement Attainment><Address><Adult><A |
$799/mo
Try GrantRadar →